Rapid Onset and Short Duration of TrenibotulinumtoxinE for Treatment of Moderate to Severe Glabellar Lines: Efficacy and Safety Results from a Phase 3 Study

Toxicon 2026

View at publisher
Authors: Marion Moers-Carpi, Cheryl Burgess, Brian S. Biesman, Deirdre Hooper, Alexander Z. Rivkin, Chung-Yi Chiang, Grace S. Park, Amy S. Weitzenfeld, Joan-En Chang-Lin
DOI: 10.1016/j.toxicon.2025.108815
Cited by: 1

Fields of Study & Subjects

Botulinum Toxin and Related Neurological Disorders Pain Mechanisms and Treatments Temporomandibular Joint Disorders

Publication details

Journal / source
Toxicon
Publisher
Elsevier BV
Volume
271
Pages
108815–108815
Publication date
8 January 2026
Language
EN